{"title":"Alzheimer's disease: new therapies and the role of biomarkers.","authors":"Kellie Dudash","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 1","pages":"22-3"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086124/pdf/bth08_1p022.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ScoliScore AIS Prognostic Test Personalizes Treatment for Children With Spinal Curve.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 2","pages":"30-1"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138384/pdf/bth08_2p030.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2.","authors":"David B Nash, Michael Toscani, F Randy Vogenberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"23-5"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278121/pdf/bh0803023.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30553400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pitting the FDA Against CMS: The good, the bad, and the ugly about \"parallel review.\".","authors":"Stephen Barlas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The good, the bad, and the ugly about the FDA/CMS parallel review process. Can it work?</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"29-30"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278123/pdf/bh0803029.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30553402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medical devices: adapting to the comparative effectiveness landscape.","authors":"Anita Mohandas, Kathleen A Foley","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Outcomes research for medical devices has always lagged, with good reason. Comparative effectiveness initiatives, though, will soon spur demand for more and better data, and that means more and better outcomes research training.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"7 2","pages":"25-8"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899795/pdf/bth07_2p025.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diagnostics come of age.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"7 2","pages":"29-30"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899799/pdf/bth07_2p029.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Specialty drug use and cost continue to rise.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"7 3","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957735/pdf/bh0703035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Of risks and dreams.","authors":"Michael D Dalzell","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"7 2","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899796/pdf/bth07_2p001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30555111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}